Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.
An early event in the metastasis of epithelial ovarian carcinoma is shedding of cells from the primary tumor into the peritoneal cavity followed by diffuse i.p. seeding of secondary lesions. Anchorage-independent metastatic cells are present as both single cells and multicellular aggregates (MCA), the latter of which adhere to and disaggregate on human mesothelial cell monolayers, subsequently forming invasive foci. Although this unique metastatic mechanism presents a distinct set of therapeutic challenges, factors that regulate MCA formation and dissemination have not been extensively evaluated. Proteolytic activity is important at multiple stages in i.p. metastasis, catalyzing migration through the mesothelial monolayer and invasion of the collagen-rich submesothelial matrix to anchor secondary lesions, and acquisition of membrane type 1 matrix metalloproteinase (MT1-MMP; MMP-14) expression promotes a collagen-invasive phenotype in ovarian carcinoma. MT1-MMP is regulated posttranslationally through multiple mechanisms including phosphorylation of its cytoplasmic tail, and the current data using ovarian cancer cells expressing wild-type, phosphomimetic (T567E-MT1-MMP), and phosphodefective (T567A-MT1-MMP) MT1-MMP show that MT1-MMP promotes MCA formation. Confluent T567E-MT1-MMP-expressing cells exhibit rapid detachment kinetics, spontaneous release as cell-cell adherent sheets concomitant with MT1-MMP-catalyzed alpha(3) integrin ectodomain shedding, and robust MCA formation. Expansive growth within three-dimensional collagen gels is also MT1-MMP dependent, with T567E-MT1-MMP-expressing cells exhibiting multiple collagen invasive foci. Analysis of human ovarian tumors shows elevated MT1-MMP in metastases relative to paired primary tumors. These data suggest that MT1-MMP activity may be key to ovarian carcinoma metastatic success by promoting both formation and dissemination of MCAs.
Moss
Natalie M
NM
Department of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine.
Barbolina
Maria V
MV
Liu
Yueying
Y
Sun
Limin
L
Munshi
Hidayatullah G
HG
Stack
M Sharon
MS
D000818:Animals; D002448:Cell Adhesion; D002450:Cell Communication; D045744:Cell Line, Tumor; D003094:Collagen; D005260:Female; D006801:Humans; D053511:Matrix Metalloproteinase 14 / Q000378:metabolism*; D009361:Neoplasm Invasiveness; D010051:Ovarian Neoplasms / Q000201:enzymology* / Q000473:pathology*; D018874:Spheroids, Cellular
D003094:Collagen; C507086:MMP14 protein, human; D053511:Matrix Metalloproteinase 14
J Biol Chem. 1997 Jan 24;272(4):2446-51
8999957
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13693-8
11698655
Cancer Res. 2001 Jun 15;61(12):4837-41
11406560
Hum Pathol. 1998 Feb;29(2):155-65
9490275
J Cell Biol. 2000 Jun 12;149(6):1309-23
10851027
Mol Cancer Res. 2009 Jun;7(6):809-20
19509114
J Carcinog. 2007 Jun 14;6:11
17567918
Gynecol Oncol. 2008 Feb;108(2):385-94
18036641
BMC Med Genomics. 2008 Aug 07;1:34
18687136
Cancer Res. 2007 Mar 1;67(5):2030-9
17332331
J Biol Chem. 2009 Jul 24;284(30):19791-9
19458085
Semin Reprod Med. 2006 Sep;24(4):270-82
16944424
Cancer Res. 1993 Oct 15;53(20):5028-32
8402695
Semin Cell Dev Biol. 2008 Feb;19(1):24-33
17702616
Int J Cancer. 2007 Oct 1;121(7):1463-72
17546601
J Biol Chem. 1996 Jul 19;271(29):17119-23
8663332
Ann Oncol. 2007 May;18(5):945-9
17298959
J Soc Gynecol Investig. 2001 Sep-Oct;8(5):299-304
11677151
Nature. 1994 Jul 7;370(6484):61-5
8015608
Cell. 2003 Jul 11;114(1):33-45
12859896
J Biol Chem. 1995 Mar 10;270(10):5331-8
7890645
Gynecol Oncol. 2004 Apr;93(1):170-81
15047232
Nat Cell Biol. 2002 Aug;4(8):632-8
12134161
J Transl Med. 2006 Jan 24;4:6
16433903
Am J Pathol. 2001 Dec;159(6):2071-80
11733357
Cancer Res. 2008 Jun 1;68(11):4311-20
18519691
Mol Carcinog. 2007 Oct;46(10):872-85
17455221
Am J Clin Pathol. 2001 Apr;115(4):517-24
11293899
Lab Invest. 1994 Mar;70(3):333-8
8145527
Carcinogenesis. 2008 Aug;29(8):1655-64
18621744
J Cell Biol. 2001 Dec 24;155(7):1345-56
11756481
Am J Pathol. 2001 Apr;158(4):1279-88
11290546
J Pathol. 1983 Mar;139(3):337-47
6834177
Clin Exp Metastasis. 1987 Apr-Jun;5(2):181-97
3297449
Biotechnol Bioeng. 2003 Jul 20;83(2):173-80
12768623
Eur J Biochem. 1997 Dec 15;250(3):751-7
9461298
Curr Opin Genet Dev. 1994 Feb;4(1):82-9
8193545
Am J Obstet Gynecol. 1974 Aug 1;119(7):991-4
4276313
Diagn Cytopathol. 2005 Nov;33(5):316-9
16240401
Kidney Int. 1990 Jun;37(6):1563-70
2362409
Gynecol Oncol. 2009 Feb;112(2):319-24
18976802
Cancer Res. 1999 Apr 1;59(7):1635-41
10197640
Cancer Res. 2008 Sep 15;68(18):7247-9
18794108
Exp Cell Res. 1985 Oct;160(2):499-513
3899694
J Biol Chem. 2007 Feb 16;282(7):4924-4931
17158885
Cell. 1999 Oct 1;99(1):81-92
10520996
Clin Exp Metastasis. 2008;25(6):643-55
18398687
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17237035
Nat Rev Cancer. 2005 May;5(5):355-66
15864277
Br J Cancer. 2007 Aug 6;97(3):358-67
17609667